France’s Strategic Council of the Healthcare Industries has announced legislative proposals to “improve the monitoring of medicines sold for export purposes”1 in a move that appears designed to prevent parallel trade.
The measures, published by the council in late October, would effectively introduce a state-backed dual pricing system...
Please login to read the full article.
